In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

LUND, SE / ACCESS Newswire / March 20, 2025 /BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech ...

T-cell lymphoma is a rare cancer that affects the lymphatic system. Learn about the types, signs, symptoms, treatments, and ...

Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy treatment regimen ...

LUND, SE / ACCESS Newswire / March 20, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class i ...

People may be a candidate if they: can safely receive high dose chemotherapy and radiation have tumors that are responsive to drugs have relapsed, aggressive lymphoma that still responds to ...

Learn more about how a research team has successfully used CRISPR gene editing in the fight against cancer.

Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumors—and ...

Cancer is one of the leading causes of death in dogs, with diagnosis ranging from lymphoma to mast cell tumors. A recent ...

UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare ...